Biogen Inc.BIIB

Close of Friday, October 23, 2026 · Biogen Inc. is trading above its Pivot, OnlyAlpha's long-term trend line.

Price

$250.69

vs its Pivot

+25.7%

OnlyAlpha Score

Trend

Above its Pivot

Last 12 months. Solid line: price. Dashed green: the Pivot.

Returns

1 month	Year to date	1 year	3 years / yr	5 years / yr
+10.7%	+42.4%	+69.7%	-1.6%	-2.3%

No dividend in the last 12 months.

Who runs and owns it

In these funds

IBB · 2.34%IYH · 0.52%IVV · 0.05%IYY · 0.05%

Big investors that own it (latest 13F)

Perceptive Advisors	0.9% of holdings
OrbiMed	0.2% of holdings

Suppliers, customers and partners

Sells to BIIB

Samsung Bioepis	anti-TNF biosimilars
Royalty Pharma	Tysabri, $250M

Partners and deals

Eisai	LEQEMBI co-development
Roche (Genentech)	Genentech arrangements
Royalty Pharma	2025 funding agreement

From the companies' own annual reports filed with the SEC.

Healthcare · Biotech

ACET -49%ALNY -23%ARGX +2%ARWR -19%ASND +3%AXSM -28%BBIO -6%BCAX -20%BMRN -4%BNTX -10%CORT +17%CRSP -7%

Get BIIB in your free daily emailAfter every close: whether BIIB is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track BIIB free → Full Stock check